0001062993-24-002020.txt : 20240205
0001062993-24-002020.hdr.sgml : 20240205
20240205183518
ACCESSION NUMBER: 0001062993-24-002020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McManus Matthew
CENTRAL INDEX KEY: 0001908268
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-17272
FILM NUMBER: 24597381
MAIL ADDRESS:
STREET 1: 15 ELIZABETH DRIVE
CITY: CHELMSFORD
STATE: MA
ZIP: 01824
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO-TECHNE Corp
CENTRAL INDEX KEY: 0000842023
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 411427402
STATE OF INCORPORATION: MN
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 614 MCKINLEY PL N E
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
BUSINESS PHONE: 6123798854
MAIL ADDRESS:
STREET 1: 614 MCKINLEY PLACE NE
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55413
FORMER COMPANY:
FORMER CONFORMED NAME: TECHNE CORP /MN/
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2024-02-01
0000842023
BIO-TECHNE Corp
TECH
0001908268
McManus Matthew
614 MCKINLEY PLACE NE
MINNEAPOLIS
MN
55413
0
1
0
0
President - DGS
0
Restricted Stock Units
2024-02-01
4
A
0
2888
0
A
Common Stock
2888
2888
D
Restricted Stock Units
2024-02-01
4
A
0
13861
0
A
Common Stock
13861
13861
D
Stock Option (Right to Buy)
68.54
2024-02-01
4
A
0
7951
0
A
2031-02-01
Common Stock
7951
7951
D
Stock Option (Right to Buy)
68.54
2024-02-01
4
A
0
15902
0
A
2031-02-01
Common Stock
15902
15902
D
Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.
Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.
/s/ Andrew Nick as Attorney-in-Fact for Matthew McManus pursuant to Power of Attorney previously filed.
2024-02-05